223 related articles for article (PubMed ID: 37306128)
1. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.
Ortblad KF; Mogere P; Omollo V; Kuo AP; Asewe M; Gakuo S; Roche S; Mugambi M; Mugambi ML; Stergachis A; Odoyo J; Bukusi EA; Ngure K; Baeten JM
J Int AIDS Soc; 2023 Jun; 26(6):e26131. PubMed ID: 37306128
[TBL] [Abstract][Full Text] [Related]
2. Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.
Ortblad KF; Kuo AP; Mogere P; Roche SD; Kiptinness C; Wairimu N; Gakuo S; Baeten JM; Ngure K
BMC Health Serv Res; 2024 May; 24(1):618. PubMed ID: 38730398
[TBL] [Abstract][Full Text] [Related]
3. Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study.
Kiptinness C; Naik P; Thuo N; Malen RC; Dettinger JC; Pintye J; Rafferty M; Jomo E; Nyamasyo N; Wood T; Isabelli P; Morris S; Hattery D; Stergachis A; Were D; Sharma M; Ngure K; Mugambi ML; Ortblad KF
Front Public Health; 2023; 11():1054559. PubMed ID: 36908449
[TBL] [Abstract][Full Text] [Related]
4. The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya.
Omollo V; Asewe M; Mogere P; Maina G; Kuo AP; Odoyo J; Oware K; Baeten JM; Kohler P; Owens T; Bukusi EA; Ngure K; Ortblad KF
J Acquir Immune Defic Syndr; 2023 Aug; 93(5):379-386. PubMed ID: 37079900
[TBL] [Abstract][Full Text] [Related]
5. Measuring the performance of HIV self-testing at private pharmacies in Kenya: a cross-sectional study.
Ortblad KF; Kwach B; Zhang S; Asewe M; Ongwen PA; Malen RC; Harkey K; Odoyo J; Gathii P; Rota G; Sharma M; Were DK; Ngure K; Omollo V; Bukusi EA
J Int AIDS Soc; 2023 Oct; 26(10):e26177. PubMed ID: 37848405
[TBL] [Abstract][Full Text] [Related]
6. Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: An analysis of routine data.
Nakambale HN; Roche SD; Mogere P; Omollo V; Kuo AP; Stergachis A; Baeten JM; Bukusi E; Ngure K; Mugambi ML; Ortblad KF
Front Reprod Health; 2023; 5():1023568. PubMed ID: 36895656
[TBL] [Abstract][Full Text] [Related]
7. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation.
Ortblad KF; Mogere P; Roche S; Kamolloh K; Odoyo J; Irungu E; Mugo NR; Pintye J; Baeten JM; Bukusi E; Ngure K;
BMC Health Serv Res; 2020 Nov; 20(1):1034. PubMed ID: 33176785
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.
Kuo AP; Roche SD; Mugambi ML; Pintye J; Baeten JM; Bukusi E; Ngure K; Stergachis A; Ortblad KF
J Int AIDS Soc; 2022 Oct; 25(10):e26027. PubMed ID: 36285619
[TBL] [Abstract][Full Text] [Related]
9. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
[TBL] [Abstract][Full Text] [Related]
10. Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions.
Roche SD; Were D; Crawford ND; Tembo A; Pintye J; Bukusi E; Ngure K; Ortblad KF
Curr HIV/AIDS Rep; 2024 Jun; 21(3):116-130. PubMed ID: 38517671
[TBL] [Abstract][Full Text] [Related]
11. Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives.
Roche SD; Wairimu N; Mogere P; Kamolloh K; Odoyo J; Kwena ZA; Bukusi EA; Ngure K; Baeten JM; Ortblad KF
AIDS Behav; 2021 Dec; 25(12):3871-3882. PubMed ID: 33826022
[TBL] [Abstract][Full Text] [Related]
12. Nurse-facilitated preexposure prophylaxis delivery for adolescent girls and young women seeking contraception at retail pharmacies in Kisumu, Kenya.
Pintye J; Odoyo J; Nyerere B; Achieng P; Araka E; Omondi C; Ortblad KF; Mugambi ML; Baeten JM; Bukusi EA
AIDS; 2023 Mar; 37(4):617-623. PubMed ID: 36653342
[TBL] [Abstract][Full Text] [Related]
13. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
[TBL] [Abstract][Full Text] [Related]
14. Effect of differentiated direct-to-pharmacy PrEP refill visits supported with client HIV self-testing on clinic visit time and early PrEP continuation.
Zewdie KB; Ngure K; Mwangi M; Mwangi D; Maina S; Etyang L; Maina G; Ogello V; Owidi E; Mugo NR; Baeten JM; Mugwanya KK
J Int AIDS Soc; 2024 Mar; 27(3):e26222. PubMed ID: 38446643
[TBL] [Abstract][Full Text] [Related]
15. Measuring the performance of computer vision artificial intelligence to interpret images of HIV self-testing results.
Roche SD; Ekwunife OI; Mendonca R; Kwach B; Omollo V; Zhang S; Ongwen P; Hattery D; Smedinghoff S; Morris S; Were D; Rech D; Bukusi EA; Ortblad KF
Front Public Health; 2024; 12():1334881. PubMed ID: 38384878
[TBL] [Abstract][Full Text] [Related]
16. Peer PrEP referral + HIV self-test delivery for PrEP initiation among young Kenyan women: study protocol for a hybrid cluster-randomized controlled trial.
Wairimu N; Malen RC; Reedy AM; Mogere P; Njeru I; Culquichicón C; McGowan M; Gao F; Baeten JM; Ngure K; Ortblad KF
Trials; 2023 Nov; 24(1):705. PubMed ID: 37925450
[TBL] [Abstract][Full Text] [Related]
17. Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics.
Irungu EM; Odoyo J; Wamoni E; Bukusi EA; Mugo NR; Ngure K; Morton JF; Mugwanya KK; Baeten JM; O'Malley G;
J Int AIDS Soc; 2021 Sep; 24(9):e25799. PubMed ID: 34496148
[TBL] [Abstract][Full Text] [Related]
18. Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya.
Wanga V; Omollo V; Bukusi EA; Odoyo JB; Morton JF; Kidoguchi L; Johnson R; Hughes JP; Celum C; Baeten JM
J Int AIDS Soc; 2020 Aug; 23(8):e25561. PubMed ID: 32820597
[TBL] [Abstract][Full Text] [Related]
19. A one-stop shop model for improved efficiency of pre-exposure prophylaxis delivery in public clinics in western Kenya: a mixed methods implementation science study.
Roche SD; Odoyo J; Irungu E; Kwach B; Dollah A; Nyerere B; Peacock S; Morton JF; O'Malley G; Bukusi EA; Baeten JM; Mugwanya KK
J Int AIDS Soc; 2021 Dec; 24(12):e25845. PubMed ID: 34898032
[TBL] [Abstract][Full Text] [Related]
20. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
